Reduced gluconeogenesis and lactate clearance in Huntington's disease

Neurobiology of Disease

Volumn 40, Issue 3, 2010, Pages 656-662

  Josefsen, Knud ^a   Nielsen, Signe M B ^a,b   Campos, André ^a   Seifert, Thomas ^b   Hasholt, Lis ^b   Nielsen, Jørgen E ^a,b   Nørremølle, Anne ^b   Skotte, Niels H ^b   Secher, Niels H ^b   Quistorff, Bjørn ^b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Brain metabolism; Exercise; Gluconeogenesis; Glucose; Liver perfusion

Indexed keywords

GLUCOSE; LACTIC ACID; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PYRUVATE KINASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BICYCLE ERGOMETRY; BRAIN METABOLISM; CLEARANCE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HUMAN; HUNTINGTON CHOREA; LIVER METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; BRAIN; EXERCISE; EXERCISE TEST; FEMALE; GLUCONEOGENESIS; HUMANS; HUNTINGTON DISEASE; LACTIC ACID; LIVER; LIVER FUNCTION TESTS; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77957766925     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2010.08.009     Document Type: Article

References (61)

1. Andreassen O.A., Dedeoglu A., Stanojevic V., et al. Huntington's disease of the endocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expression. Neurobiol. Dis. 2002, 11:410-424.
2. Aziz N.A., Pijl H., Frolich M., van der Graaf A.W., Roelfsema F., Roos R.A. Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease. J. Clin. Endocrinol. Metab. 2009, 94:1223-1228.
3. Bergersen L.H. Is lactate food for neurons? Comparison of monocarboxylate transporter subtypes in brain and muscle. Neuroscience 2007, 145:11-19.
4. Bjorkqvist M., Petersen A., Bacos K., et al. Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease. Hum. Mol. Genet. 2006, 15:1713-1721.
5. Bolt J.M., Lewis G.P. Huntington's chorea. A study of liver function and histology. Q. J. Med. 1973, 42:151-174.
6. Chaturvedi R.K., Adhihetty P., Shukla S., et al. Impaired PGC-1alpha function in muscle in Huntington's disease. Hum. Mol. Genet. 2009, 18:3048-3065.
7. Chiang M.C., Chen H.M., Lee Y.H., et al. Dysregulation of C/EBPalpha by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease. Hum. Mol. Genet. 2007, 16:483-498.
8. Chiu E., Mackay I.R., Bhathal P.B. Hepatic morphology in Huntington's chorea. J. Neurol. Neurosurg. Psychiatry 1975, 38:1000-1002.
9. Dalsgaard M.K. Fuelling cerebral activity in exercising man. J. Cereb. Blood Flow Metab. 2006, 26:731-750.
10. Dautry C., Conde F., Brouillet E., et al. Serial 1H-NMR spectroscopy study of metabolic impairment in primates chronically treated with the succinate dehydrogenase inhibitor 3-nitropropionic acid. Neurobiol. Dis. 1999, 6:259-268.
11. Deschenes M.R., Carter J.A., Matney E.N., Potter M.B., Wilson M.H. Aged men experience disturbances in recovery following submaximal exercise. J. Gerontol. A Biol. Sci. Med. Sci. 2006, 61:63-71.
12. Deschenes M.R., Connell A.M., Jackson E.M., Taylor J.L., Glass E.K. A comparison of physiological variables in aged and young women during and following submaximal exercise. Am. J. Hum. Biol. 2009, 21:836-843.
13. Duran R., Barrero F.J., Morales B., Luna J.D., Ramirez M., Vives F. Oxidative stress and plasma aminopeptidase activity in Huntington's disease. J. Neural Transm. 2010, 117:325-332.
14. Eroglu Y., Byrne W.J. Hepatic encephalopathy. Emerg. Med. Clin. North Am. 2009, 27:401-414.
15. Ferrier C., Jennings G.L., Eisenhofer G., et al. Evidence for increased noradrenaline release from subcortical brain regions in essential hypertension. J. Hypertens. 1993, 11:1217-1227.
16. Gertz E.W., Wisneski J.A., Stanley W.C., Neese R.A. Myocardial substrate utilization during exercise in humans. Dual carbon-labeled carbohydrate isotope experiments. J. Clin. Invest. 1988, 82:2017-2025.
17. Good C.A., Kramer H., Somogyi M. The determination of glycogen. J. Biol. Chem. 1933, 100:485-491.
18. Hanson R.W. Thematic minireview series: a perspective on the biology of phosphoenolpyruvate carboxykinase 55years after its discovery. J. Biol. Chem. 2009, 284:27021-27023.
19. Harms L., Meierkord H., Timm G., Pfeiffer L., Ludolph A.C. Decreased N-acetyl-aspartate/choline ratio and increased lactate in the frontal lobe of patients with Huntington's disease: a proton magnetic resonance spectroscopy study. J. Neurol. Neurosurg. Psychiatry 1997, 62:27-30.
20. Hespel P., Lijnen P., Vanhees L., et al. Differentiation of exercise-induced metabolic responses during selective beta 1- and beta 2-antagonism. Med. Sci. Sports Exerc. 1986, 18:186-191.
21. Hess B., Wieker H.J. Merhods in Enzymatic Analysis 1974, 804-811. Verlag Chemie, Weinheim. H. Bergmeyer (Ed.).
22. Hoang T.Q., Bluml S., Dubowitz D.J., et al. Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases. Neurology 1998, 50:1033-1040.
23. Hurlbert M.S., Zhou W., Wasmeier C., Kaddis F.G., Hutton J.C., Freed C.R. Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes. Diabetes 1999, 48:649-651.
24. Ide K., Schmalbruch I.K., Quistorff B., Horn A., Secher N.H. Lactate, glucose and O2 uptake in human brain during recovery from maximal exercise. J. Physiol. 2000, 522:159-164.
25. Jenkins B.G., Koroshetz W.J., Beal M.F., Rosen B.R. Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy. Neurology 1993, 43:2689-2695.
26. Jorgensen L.G., Perko M., Hanel B., Schroeder T.V., Secher N.H. Middle cerebral artery flow velocity and blood flow during exercise and muscle ischemia in humans. J. Appl. Physiol. 1992, 72:1123-1132.
27. Josefsen K., Lee Y.C., Thams P., Efendic S., Nielsen J.H. AKAP 18 alpha and gamma have opposing effects on insulin release in INS-1E cells. FEBS Lett. 2010, 584:81-85.
28. Kunst A., Draeger B., Ziegenhorn J. Methods of Enzymatic Analysis 1974, 163-172. Verlag Chemie, Weinheim. H.U. Bergmayer (Ed.).
29. Lauritsen T.L., Grunnet N., Rasmussen A., Secher N.H., Quistorff B. The effect of hepatectomy on glucose homeostasis in pig and in man. J. Hepatol. 2002, 36:99-104.
30. Leblhuber F., Peichl M., Neubauer C., et al. Serum dehydroepiandrosterone and cortisol measurements in Huntington's chorea. J. Neurol. Sci. 1995, 132:76-79.
31. Li S.H., Schilling G., Young W.S., et al. Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron 1993, 11:985-993.
32. Mangiarini L., Sathasivam K., Seller M., et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996, 87:493-506.
33. Martin W.R., Wieler M., Hanstock C.C. Is brain lactate increased in Huntington's disease?. J. Neurol. Sci. 2007, 263:70-74.
34. Newsholme E.A., Leech A. Biochemistry for the medical Sciences 1983, 209-229. Weiley, New York.
35. Nicoli F., Vion-Dury J., Maloteaux J.M., et al. CSF and serum metabolic profile of patients with Huntington's chorea: a study by high resolution proton NMR spectroscopy and HPLC. Neurosci. Lett. 1993, 154:47-51.
36. Nielsen H.B. pH after competitive rowing: the lower physiological range?. Acta Physiol. Scand. 1999, 165:113-114.
37. Nielsen H.B., Bredmose P.P., Strömstad M., Volianitis S., Quistorff B., Secher N.H. Bicarbonate attenuates arterial desaturation during maximal exercise in humans. J. Appl. Physiol. 2002, 93:724-731.
38. Norremolle A., Riess O., Epplen J.T., Fenger K., Hasholt L., Sorensen S.A. Trinucleotide repeat elongation in the Huntingtin gene in Huntington disease patients from 71 Danish families. Hum. Mol. Genet. 1993, 2:1475-1476.
39. Passonneau J.V., Lowry O.H. Enzymatic analysis: a practical guide 1993, Humana Press, New Jersey.
40. Petrescu I., Bojan O., Saied M., Barzu O., Schmidt F., Kuhnle H.F. Determination of phosphoenolpyruvate carboxykinase activity with deoxyguanosine 5'-diphosphate as nucleotide substrate. Anal. Biochem. 1979, 96:279-281.
41. Phan J., Hickey M.A., Zhang P., Chesselet M.F., Reue K. Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models. Hum. Mol. Genet. 2009, 18:1006-1016.
42. Pilkis S.J., Granner D.K. Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu. Rev. Physiol. 1992, 54:885-909.
43. Putman C.T., Jones N.L., Lands L.C., Bragg T.M., Hollidge-Horvat M.G., Heigenhauser G.J. Skeletal muscle pyruvate dehydrogenase activity during maximal exercise in humans. Am. J. Physiol. 1995, 269:E458-E468.
44. Quistorff B., Grunnet N., Cornell N.W. Digitonin perfusion of rat liver. A new approach in the study of intra-acinar and intracellular compartmentation in the liver. Biochem. J. 1985, 226:289-297.
45. Quistorff B., Secher N.H., Van Lieshout J.J. Lactate fuels the human brain during exercise. FASEB J. 2008, 22:3443-3449.
46. Rhee J., Inoue Y., Yoon J.C., et al. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:4012-4017.
47. Ross B.D., Hems R., Freedland R.A., Krebs H.A. Carbohydrate metabolism of the perfused rat liver. Biochem. J. 1967, 105:869-875.
48. Saleh N., Moutereau S., Durr A., et al. Neuroendocrine disturbances in Huntington's disease. PLoS One 2009, 4:e4962.
49. Sathasivam K., Hobbs C., Turmaine M., et al. Formation of polyglutamine inclusions in non-CNS tissue. Hum. Mol. Genet. 1999, 8:813-822.
50. Secher N.H., Clausen J.P., Klausen K., Noer I., Trap-Jensen J. Central and regional circulatory effects of adding arm exercise to leg exercise. Acta Physiol. Scand. 1977, 100:288-297.
51. Simpson I.A., Carruthers A., Vannucci S.J. Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J. Cereb. Blood Flow Metab. 2007, 27:1766-1791.
52. Sumida K.D., Urdiales J.H., Donovan C.M. Impact of flow rate on lactate uptake and gluconeogenesis in glucagon-stimulated perfused livers. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E185-E191.
53. The Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983.
54. Thomas E.A. Striatal specificity of gene expression dysregulation in Huntington's disease. J. Neurosci. Res. 2006, 84:1151-1164.
55. Tsang T.M., Woodman B., McLoughlin G.A., et al. Metabolic characterization of the R6/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy. J. Proteome Res. 2006, 5:483-492.
56. van Hall G., Stromstad M., Rasmussen P., et al. Blood lactate is an important energy source for the human brain. J. Cereb. Blood Flow Metab. 2009, 29:1121-1129.
57. Van Raamsdonk J.M., Murphy Z., Selva D.M., et al. Testicular degeneration in Huntington disease. Neurobiol. Dis. 2007, 26:512-520.
58. Weydt P., Pineda V.V., Torrence A.E., et al. Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. Cell Metab. 2006, 4:349-362.
59. Yang J., Reshef L., Cassuto H., Aleman G., Hanson R.W. Aspects of the control of phosphoenolpyruvate carboxykinase gene transcription. J. Biol. Chem. 2009, 284:27031-27035.
60. Yoon J.C., Puigserver P., Chen G., et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 2001, 413:131-138.
61. Zabel C., Mao L., Woodman B., et al. A large number of protein expression changes occur early in life and precede phenotype onset in a mouse model for huntington disease. Mol. Cell. Proteomics 2009, 8:720-734.